Caresyntax empowers surgeons and providers with data-driven surgery using AI, automation, and OR analytics.
2023
Year invested
Fund II
MTIP Fund
Berlin, Germany
Location
Active Investment
Investment status
Digital Surgery
Segment
Caresyntax’s digital surgery platform uses proprietary software and artificial intelligence (AI) to analyze large volumes of real-world data in and around the operating room (OR) to deliver insights that can be used immediately by the care team and longer-term by a variety of critical stakeholders, including surgeons to assess and improve care. Caresyntax also offers virtual, real-time access to outside experts, such as medical school instructors or medical device representatives, through its digital platform. With its attractive B2B software business model with recurring revenues, Caresyntax software is used in more than 2,800 operating rooms worldwide and supports surgical teams in over three million procedures per year.
As a long-term investor with a track record of creating successful and sustainable businesses, our goal is to deliver attractive strategic and financial returns to our investors.
.svg)
.svg)
